X4 Pharmaceuticals
XFOR
#8094
Rank
HK$2.72 B
Marketcap
HK$28.93
Share price
0.27%
Change (1 day)
140.88%
Change (1 year)

Revenue for X4 Pharmaceuticals (XFOR)

Revenue in 2026 (TTM): HK$70.43 Million

According to X4 Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is HK$70.66 Million. In 2025 the company made a revenue of HK$0.27 Billion an increase over the revenue in the year 2024 that were of HK$19.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for X4 Pharmaceuticals from 2017 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) HK$70.43 M-74.22%
2025 HK$0.27 B1276.25%
2024 HK$19.85 M
2023 N/A
2022 N/A
2021 N/A-100%
2020 HK$23.25 M
2019 N/A-100%
2018 HK$27.4 M
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA